BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Snider EJ, Kaz AM, Inadomi JM, Grady WM. Chemoprevention of esophageal adenocarcinoma. Gastroenterol Rep (Oxf) 2020;8:253-60. [PMID: 32843972 DOI: 10.1093/gastro/goaa040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang C, Huang C, Nguyen PA, Lin M, Yeh C, Islam MM, Rahmanti AR, Yang H. Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals. Cancers 2022;14:1211. [DOI: 10.3390/cancers14051211] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Yao H, Wang L, Li H, Xu S, Bai Z, Wu Y, Chen H, Goyal H, Qi X. Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis. Expert Rev Clin Pharmacol 2021;:1-10. [PMID: 34806503 DOI: 10.1080/17512433.2022.2008909] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Scarpignato C, Wang DH. Cancer Prevention in Patients with GERD and Barrett’s Esophagus—Medicine. Foregut 2021;1:50-62. [DOI: 10.1177/2634516121993676] [Reference Citation Analysis]
4 Hippisley-cox J, Mei XW, Tan PS, Fitzgerald R, Coupland C, Panday-ghimire B, Offman J, Sasieni P. Chronic acid-suppressant use and risk of Oesophageal cancer: protocol for a longitudinal study using a large population based cohort.. [DOI: 10.1101/2021.02.15.21251618] [Reference Citation Analysis]